Literature DB >> 26586621

Hydroxycinnamic acid amides from Scopolia tangutica inhibit the activity of M1 muscarinic acetylcholine receptor in vitro.

Yan Zhang1, Zhen Long2, Zhimou Guo2, Zhiwei Wang3, Xiuli Zhang2, Richard D Ye4, Xinmiao Liang2, Olivier Civelli3.   

Abstract

Scopolia tangutica Maxim (S. tangutica) extracts have been traditionally used as antispasmodic, sedative, and analgesic agents in Tibet and in the Qinghai province of China. Their active compositions are however poorly understood. We have recently isolated five new hydroxycinnamic acid (HCA) amides along with two known HCA amides, one cinnamic acid amide from these extracts. In this study, we evaluate their abilities to inhibit carbacol-induced activity of M1 muscarinic acetylcholine receptor along with the crude extracts. Chinese hamster ovary cells stably expressing the recombinant human M1 receptor (CHO-M1 cells) were employed to evaluate the anticholinergic potentials. Intracellular Ca(2+) changes were monitored using the FLIPR system. Five HCA amides as well as the crude S. tangutica extract displayed dose-dependent inhibitory effects against M1 receptor. These findings demonstrate that HCA amides are part of the M1 receptor-inhibiting principles of S. tangutica. Since blockade of parasympathetic nerve impulse transmission through the inhibition of the M1 receptor lessens smooth muscle spasms, our findings provided a molecular explanation for the traditional use of S. tangutica against spasm.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hydroxycinnamic acid amides; M1 muscarinic acetylcholine receptor; Scopolia tangutica Maxim

Mesh:

Substances:

Year:  2015        PMID: 26586621      PMCID: PMC4698058          DOI: 10.1016/j.fitote.2015.11.007

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  26 in total

1.  Two-dimensional strong cation exchange/positively charged reversed-phase liquid chromatography for alkaloid analysis and purification.

Authors:  Zhen Long; Zhimou Guo; Xingya Xue; Xiuli Zhang; Xinmiao Liang
Journal:  J Sep Sci       Date:  2013-11-15       Impact factor: 3.645

Review 2.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

3.  Identification of a family of muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; N J Buckley; A C Young; M R Brann
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

4.  Preparation and biological assessment of hydroxycinnamic acid amides of polyamines.

Authors:  Solomon Fixon-Owoo; Frédéric Levasseur; Keith Williams; Thomas N Sabado; Mike Lowe; Markus Klose; A Joffre Mercier; Paul Fields; Jeffrey Atkinson
Journal:  Phytochemistry       Date:  2003-06       Impact factor: 4.072

5.  Differential neuropsychopharmacological influences of naturally occurring tropane alkaloids anisodamine versus scopolamine.

Authors:  Wei-Wei Zhang; Ming-Ke Song; Yong-Yao Cui; Hao Wang; Liang Zhu; Yin-Yao Niu; Li-Min Yang; Yang Lu; Hong-Zhuan Chen
Journal:  Neurosci Lett       Date:  2008-07-23       Impact factor: 3.046

6.  Phenylpropanoid polyamine conjugate biosynthesis in Arabidopsis thaliana flower buds.

Authors:  Christin Fellenberg; Christoph Böttcher; Thomas Vogt
Journal:  Phytochemistry       Date:  2009-09-15       Impact factor: 4.072

7.  Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock.

Authors:  R J Xiu; D E Hammerschmidt; P A Coppo; H S Jacob
Journal:  JAMA       Date:  1982-03-12       Impact factor: 56.272

Review 8.  Pharmacotherapy for Parkinson's disease.

Authors:  Jack J Chen; David M Swope
Journal:  Pharmacotherapy       Date:  2007-12       Impact factor: 4.705

9.  BmK-YA, an enkephalin-like peptide in scorpion venom.

Authors:  Yan Zhang; Junyan Xu; Zhiwei Wang; Xiuli Zhang; Xinmiao Liang; Olivier Civelli
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

Review 10.  Anticholinergics for symptomatic management of Parkinson's disease.

Authors:  R Katzenschlager; C Sampaio; J Costa; A Lees
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  2 in total

1.  Discovery of new muscarinic acetylcholine receptor antagonists from Scopolia tangutica.

Authors:  Nana Du; Yanfang Liu; Xiuli Zhang; Jixia Wang; Jianqiang Zhao; Jian He; Han Zhou; Lijuan Mei; Xinmiao Liang
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

Review 2.  Natural Antispasmodics: Source, Stereochemical Configuration, and Biological Activity.

Authors:  Edith Fabiola Martínez-Pérez; Zaida N Juárez; Luis R Hernández; Horacio Bach
Journal:  Biomed Res Int       Date:  2018-10-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.